FZU researchers are taking part in developing a system for a timely detection of melanoma in humans
A device that uses a single blood drop to determine whether a patient has a melanoma, and, possibly, at what stage, is being developed by an international research team that includes researchers from the Institute of Physics of the Czech Academy of Sciences led by the researcher Jakub Dostálek. As part of the VerSiLiB project, they are building a device capable of capturing and detecting even very small amounts of molecules produced by tumour cells, which can be used as biomarkers.